Building Your Child's Care Team for JPD
At a Glance
Children with Juvenile Paget disease benefit from a coordinated care team led by a pediatric metabolic bone specialist, with genetics and other experts added as needed. Complete records and a shared care plan help teams monitor treatment and daily needs safely.
Because Juvenile Paget Disease (JPD) is an ultra-rare condition that can affect multiple parts of the body, no single doctor can manage it alone. Building a dedicated “care team” is one of the most important steps you can take to ensure your child receives comprehensive, safe, and proactive care [1][2]. However, families do not need to seek out every specialist immediately; the best approach is to establish a core team and add others as guided by findings.
The Core Team: Your Child’s Medical Home
Effective JPD management requires a multidisciplinary approach—a core team that monitors both the skeleton and helps coordinate evaluations of the “extraskeletal” (non-bone) parts of the body as needed [2][1].
The Lead Specialist: Pediatric Metabolic Bone Expert
Your “quarterback” is typically a pediatric endocrinologist or a metabolic bone specialist. Because JPD is so rare, you should look for a specialist affiliated with a major academic medical center or a rare bone disease clinic [1].
- Their Role: They manage the diagnostic process, interpret age-adjusted alkaline phosphatase (ALP) levels, decide on medication types and doses, and monitor for treatment safety (like calcium levels) [3][4].
- Tip: If traveling to a rare-bone center is difficult, ask your local team about remote consultations with an expert center.
The Genetics Team
- Clinical Geneticist / Genetic Counselor: They interpret the specific genetic mutation (such as TNFRSF11B) and provide counseling for the family regarding inheritance, meaning of variants of uncertain significance, and future risks [5][6].
Adding Specialists Based on Findings
JPD can affect systems beyond the bones, so these experts may be added to your team according to findings and specialist advice:
- Audiologist & ENT: These specialists monitor for sensorineural hearing loss, and an ENT is vital for planning safe care if your child ever needs surgery due to rare airway cartilage involvement [2][7].
- Ophthalmologist: Added if there are concerns about retinal changes (like angioid streaks) [8][1].
- Cardiologist or Vascular Specialist: Added only if symptoms or specialist assessment warrant monitoring for blood vessel changes, such as vascular calcification or aneurysms [1][9].
The Mobility and Support Team
- Pediatric Orthopedist & Physiatrist: They focus on physical structure and rehabilitation, monitoring for leg bowing or fractures, and providing strategies or assistive devices to keep your child moving safely [2][10][3][11].
- Support Services: A pediatric dentist, social worker, care coordinator, and school-support services can provide critical help with daily life and accommodations.
Preparing for Your First Specialist Visit
When you meet with a JPD expert for the first time, you are often providing them with the “roadmap” they need to understand your child’s unique history. Bringing the following records can significantly speed up the process [12][6]:
- Genetic Testing Reports: Bring the full, multi-page report from the lab (not just a summary), including any testing done on parents [12][5].
- Serial Laboratory Results: A chronological list of every ALP and bone-turnover test your child has had. Seeing how these numbers have changed over time is more useful than a single “snapshot” [13][12].
- Original Imaging (on a CD or Portal): Radiologists need to see the actual X-rays or bone scans, not just the written reports, to look for specific patterns of bone expansion and thickening [10][6].
- Growth and Milestone Records: Bring your child’s growth charts (height and weight over time) and notes on when they reached milestones like sitting, crawling, or walking [2][4].
Coordinating Care and Daily Life
Because JPD is complex, it is essential that your specialists talk to one another. Ask your lead specialist if they can provide a “shared care plan”—a written document that outlines the monitoring schedule, current medications, and what to do in an emergency [14][15]. This plan ensures that your local pediatrician and all your consultants are on the same page.
For daily life, work with your team to establish safe movement practices, physical or occupational therapy plans, and school accommodations. Families should not impose broad activity restrictions or begin strenuous exercise without the treating team’s guidance.
Common questions in this guide
Which specialists should care for a child with Juvenile Paget disease?
How can I find a specialist who treats Juvenile Paget disease?
What records should I bring to my child’s first JPD specialist visit?
How can my child’s doctors coordinate Juvenile Paget disease care?
Should my child avoid exercise or normal activities because of JPD?
Get notified when new evidence is published on Juvenile Paget disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Juvenile Paget disease.
Polyzos SA, Cundy T, Mantzoros CS
Metabolism: clinical and experimental 2018; (80()):15-26 doi:10.1016/j.metabol.2017.10.007.
PMID: 29080812 - 2
Loss of Functional Osteoprotegerin: More Than a Skeletal Problem.
Grasemann C, Unger N, Hövel M, et al.
The Journal of clinical endocrinology and metabolism 2017; (102(1)):210-219 doi:10.1210/jc.2016-2905.
PMID: 27809640 - 3
Clinical course in two children with Juvenile Paget's disease during long-term treatment with intravenous bisphosphonates.
Höppner J, Steff K, Misof BM, et al.
Bone reports 2021; (14()):100762 doi:10.1016/j.bonr.2021.100762.
PMID: 33850973 - 4
Rhizomelia and Impaired Linear Growth in a Girl with Juvenile Paget Disease: The Natural History of the Condition.
Höppner J, Steff K, Lobert F, et al.
Hormone research in paediatrics 2021; (94(3-4)):151-158 doi:10.1159/000517164.
PMID: 34261073 - 5
Juvenile Paget disease with unique compound heterozygous sequence variants in the TNFRSF11B gene.
Horackova J, Taslerova R, Bayer M, et al.
Orphanet journal of rare diseases 2025; (20(1)):409 doi:10.1186/s13023-025-03804-2.
PMID: 40775369 - 6
Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).
Whyte MP, Campeau PM, McAlister WH, et al.
Bone 2020; (137()):115364 doi:10.1016/j.bone.2020.115364.
PMID: 32298837 - 7
Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease.
Gottesman GS, Madson KL, McAlister WH, et al.
American journal of medical genetics. Part A 2016; (170A(4)):978-85 doi:10.1002/ajmg.a.37536.
PMID: 26762549 - 8
ANGIOID STREAKS: A Comprehensive Review From Pathophysiology to Treatment.
Chatziralli I, Saitakis G, Dimitriou E, et al.
Retina (Philadelphia, Pa.) 2019; (39(1)):1-11 doi:10.1097/IAE.0000000000002327.
PMID: 30260918 - 9
Early-onset juvenile Paget disease associated with a homozygous intronic TNFRSF11B variant: a 2-year follow-up.
Meral R, Gökoğlu M
Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0332.
PMID: 42528457 - 10
Juvenile Paget's disease with compound heterozygous mutations in TNFRSF11B presenting with recurrent clavicular fractures and a mild skeletal phenotype.
Naot D, Wilson LC, Allgrove J, et al.
Bone 2020; (130()):115098 doi:10.1016/j.bone.2019.115098.
PMID: 31655221 - 11
Juvenile Paget's Disease: Report of a successful treatment throughout the complete growth of a patient with a missense TNFRSF11B mutation.
Prata AR, Saraiva J, Salgado M, Estanqueiro P
Joint bone spine 2021; (88(6)):105243 doi:10.1016/j.jbspin.2021.105243.
PMID: 34166796 - 12
The first neonatal case of Juvenile Paget disease with homozygous deletion in the TNFRSF11B gene.
Yarci E, Turen B, Ozturk Yarci D, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(10)):1060-1065 doi:10.1515/jpem-2026-0056.
PMID: 42112796 - 13
Alkaline phosphatase in paediatric practice: a practical approach with a proposed diagnostic algorithm.
Parys J, Nowicki JK, Jakubowska-Pietkiewicz E
Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0400.
PMID: 42867915 - 14
Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease.
Gonc EN, Ozon A, Buyukyilmaz G, et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2018; (29(6)):1471-1474 doi:10.1007/s00198-018-4443-7.
PMID: 29502293 - 15
Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review.
Wang D, Tang X, Shi Q, et al.
Translational pediatrics 2023; (12(3)):470-486 doi:10.21037/tp-22-276.
PMID: 37035391
This page offers general information about organizing care for a child with Juvenile Paget disease and does not constitute medical advice. Your child’s metabolic bone specialist and care team should tailor referrals, monitoring, activity guidance, and treatment to your child’s needs.